Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Potential of Oral Camostat in Early COVID-19 Disease in an Ambulatory Setting to Reduce Viral Load and Disease Burden

NCT04625114 is registered in ClinicalTrials.gov with University Hospital, Ghent as lead sponsor.

NCT NCT04625114
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04625114 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Potential of Oral Camostat in Early COVID-19 Disease in an Ambulatory Setting to Reduce Viral Load and Disease Burden
Lead sponsor
University Hospital, Ghent
Phase
Phase 2
Overall status
Terminated
Start date
November 4, 2020
Completion date
July 12, 2022
Enrollment
108 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19